Log in

News Blog

  • July 12, 2022 11:39 AM | Leya Duigu (Administrator)

    The ISNCC Board of Directors is pleased to announce the release of the Society’s 2022-2025 Strategic Plan. The plan continues ISNCC’s long tradition as the global leader in cancer nursing and reconfirms our commitment to the identification, engagement, and development of nurses across the world as essential health care providers in cancer care and control.

    The 2022-2025 Strategic Plan includes the following strategic directions:

    • Build and strengthen the cancer nursing workforce across the world
    • Influence global health policy
    • Advance and apply knowledge
    • Leverage partnerships with members and global citizens

    Each direction is associated with a range of key activities that will enable ISNCC to achieve its mission to lead the global nursing community to reduce the burden of cancer.

    Open ISNCC 2022-2025 Strategic Plan
  • July 01, 2022 11:36 AM | Leya Duigu (Administrator)


    Professor Winnie So, BN, MHA, Ph.D., FAAN, will commences her four-year term as President of ISNCC from July 1st, 2022. Winne is a Professor at the Nethersole School of Nursing, The Chinese University of Hong Kong, and a Visiting Professor at the School of Nursing, Shandong University of Traditional Chinese Medicine. Winnie’s research interest focuses on cancer and palliative care, especially in relation to cancer prevention and early detection of cancer, supportive care needs, symptom experience, and quality of life of cancer patients. She has published over 170 papers in peer-reviewed journals and delivered more than 110 invited presentations/lectures at national/international conferences, workshops, research institutes, and universities. She is also the Editor-in-Chief of the Asia-Pacific Journal of Oncology Nursing and an Associate Editor of Cancer Nursing.


  • July 01, 2022 11:33 AM | Leya Duigu (Administrator)

    The ISNCC Nominations and Awards Committee is pleased to announce outcomes for election to three vacant Board of Director Portfolio positions.

    Corporate & Philanthropic Development Portfolio: Josephine Visser RN, BSN, OCN
    Joanne is currently Oncology Clinical Territory Manager, Takeda Oncology, USA. She has extensive professional experience in a range of clinical and education roles. She has been an active member of the Oncology Nursing Society in the USA, contributing to a number of projects and committee roles. Joanne has been a member of the Corporate and Philanthropic Committee of ISNCC since 2019. She has been an active member with participation and bringing ideas/suggestions to assist with the goals of the strategic plan of the committee.

    Knowledge Development & Dissemination Portfolio: Meinir Krishnasamy, B.A.(Hons), RGN, Master of Advanced Clinical Practice (Cancer Nursing), PhD
    Meinir is currently Director, Academic Nursing Unit, Peter MacCallum Cancer Centre, Melbourne, Research and Education Lead - Nursing, Victorian Comprehensive Cancer Centre (VCCC) Alliance, and Professor of Cancer Nursing, University of Melbourne. She has made significant contributions to cancer nursing over the past 30 years including being a long standing and active member of ISNCC, contributing to and participating in the International Conference on Cancer. More recently, Meinir has been a member of ISNCC’s Policy and Advocacy Committee.

    Member Development Portfolio: Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP®, CGNC®, FAAN
    Lisa is currently Global Nurse Consultant and Oncology Nurse Practitioner, St. Joseph Hospital. She has more than four decades as a registered oncology nurse and certified nurse practitioner, and experience as a tenured faculty, consultant and author. Lisa is a longtime member of the Oncology Nursing Society (ONS) in the USA and has held positions on ONS research advisory panels. She was the first ONS Chief Clinical Officer. Lisa is also a longtime member of ISNCC and currently serves as an author mentor for Cancer Nursing.

    The three successful candidates will take up their Board positions for a four-year term from July 1st, 2022. They join other continuing members of the Board, including:

    • Winnie So, President (from 1st July 2022)
    • Linda Watson, Secretary/Treasurer
    • Patsy Yates, Past President (from 1st July 2022)
    • Suzanne Bishaw, Conference Management Portfolio
    • Julia Downing, Policy and Advocacy Portfolio
    • Yongyi Chen, Communications Portfolio

    I would also like to thank outgoing board members, Raymond Chan, Andrew Dimech, and Scarlott Mueller, for their outstanding contribution to the Board over the past four years.

  • June 16, 2022 3:32 AM | Anonymous

    AUTHORS: Margaret I Fitch RN PhD, Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada
    Christopher J Longo PhD, Health Policy and Management, DeGroote School of Business, MacMaster University, Hamilton, Canada

    Cancer and its treatments have many impacts and leave individuals and families coping with a range of challenges. One of the challenges we are understanding more about is financial toxicity. The term reflects both hardship and distress arising from the financial burden experienced during and following cancer treatment.

    Initially, exploration of financial impact following a cancer diagnosis only focused on calculating costs of treatments. Investigations then moved on to explore the amount of ‘out-of-pocket’ costs which patients incurred. These are defined as expenses not covered by the healthcare system or reimbursed through health insurance. They can include costs for hospital bills, medications, supplies, counselling, transportation, and parking. These objective measures failed to capture the extent and complexity of the financial impact. More recently, subjective measures concerning distress and impact on quality of living have been explored.

    Almost all people diagnosed with cancer will report having added expenses. Cancer patients/survivors report there are often “out-of-pocket” expenses they must pay themselves related to having cancer and being treated. The actual amounts vary from country to country but exist regardless of the type of healthcare system coverage in a country (i.e., public, private. combination).

    Many individuals also report a loss of income which they attribute to cancer. Many who are working at the time of diagnosis report not being able to work for a time. This can also apply to family members. Some individuals will be covered by work leave or sick coverage plans, but this will vary from person to person. Those who are self-employed often face significant challenges if they are unable to work, as do those in fixed incomes. Additionally, whether an individual has private insurance coverage will influence the amount of income lost.  

    Patients use a variety of strategies to deal with the financial demands: using savings, reducing spending, forgoing leisure activities, or setting aside plans for items such as vacations, education, and home renovations. In some instances, they forgo medical care or medications.

    The emotional distress engendered by financial burden varies from person to person. The extent of this strain is linked to such factors as financial status at the time of diagnosis, financial acumen, having insurance coverage, and ability to access financial support programs.

     It is important that a conversation occur soon after diagnosis about the potential for financial burden. Patients need to be prepared for the financial impact and not taken by surprise. They need to know what resources are available to them. Some will have sufficient resources of their own and be able to manage without additional intervention, but others will benefit from additional assistance. The role of financial navigators has been implemented successfully in some cancer programs. 

    Screening for distress surrounding financial toxicity should be incorporated into routine practice. Often the financial impact emerges during treatment and may continue long after treatment has finished. It is important to identify those who would benefit from intervention as early as possible so that effects can be mitigated.  

    Selected References

    • Fitch MI, Sharp L, Hanly P, Longo CJ. Experiencing financial toxicity associated with cancer in publicly funded healthcare systems: A systematic review of qualitative studies [e-pub ahead of print]. J Cancer Surviv. doi: https://doi.org/10.1007/s11764-021-01025-7.
    • Fitch MI, Longo CJ, Chan RJ. Cancer patients’ perspectives on financial burden in a universal healthcare system: analysis of qualitative data from participants from 20 provincial cancer centres in Canada. Patient Educ Counsel. 2021;104:903–910. https://doi.org/10.1016/j. pec.2020.08.013.
    • Longo CJ.  Linking Intermediate to Final “Real-World” Outcomes: Is Financial Toxicity a Reliable Predictor of Poorer Outcomes in Cancer? Curr Oncol. 2022; 29: 2483–2489. https://doi.org/10.3390/curroncol29040202
    • Longo CJ, Fitch MI, Banfield L, Hanly P, Yabroff KR, Sharp L. Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review. Support Care Cancer. 2020;28(10):4645–65. https://doi.org/10.1007/s00520-020-05620-9 Epub 2020 Jul 11 32653957.

    This study was presented at ICCN2022 virtual conference.

    Registration for ICCN2022 virtual library now open. For more information, please access https://www.iccn2022.com/registration/


  • June 16, 2022 3:31 AM | Anonymous

    Authors:
    Marie Goretti Uwayezu RN MScN1
    Bellancille Nikuze RN MScN1
    Emile Munyembaraga RN MScN1
    Margaret I Fitch RN PhD1,2,3

    1Scholl of Nursing and Midwifery, University of Rwanda, Kigali, Rwanda
    2Bloomberg Faculty of Nursing, University of Toronto, Toronto Canada
    3School of Nursing, New York University, New York, USA

    The burden of cancer is increasing around the world with almost three-quarters of this burden expected to occur in middle- and low-income countries. The incidence is expected to double by 2050 in some Sub-Sahara African countries (Fidler et al., 2018). Rwanda lies at the heart of East Africa and has about 12.8 million inhabitants. Eighty-three percent live rurally in nuclear family compounds. The country can be held up as a model for how a resource-limited country can build a strong health care system.

    The Rwandan health care system is a decentralized and multilayered system with specialized centres for some diseases. Cancer is one such specialty which is growing in terms of infrastructure and human resources. As of 2021 an estimated 10,704 new cancer cases were diagnosed annually and 7662 deaths occurred. The most frequent female cancer was cervical (12.2%) and for males was prostate (15.6%). Cancer surgery is available in district hospitals while chemotherapy and radiation treatment are available in selected specialty programs. Like other African countries, people face challenges in accessing diagnosis and treatment for cancer including lack of specialty centres close to home; transportation to screening, diagnosis and treatment facilities; financial concerns; and pain and symptom management. As a result many face a late diagnosis (Stage 3 or 4).

    Rwanda has shown leadership for cancer control. A national five-year plan for cancer control exists as well as a comprehensive prevention program for HPV vaccination and clearly articulated palliative care policy, guidelines, and standards. The country launched its own morphine production and distribution program to meet the needs for pain management in palliative patients.

    Advanced nursing and midwifery education was established in 1996 at the Kigali Health Institute with opportunities for advanced diploma, bachelor and master’s preparation. In 2007, five Schools of Nursing were established which, in 2013, were joined through a Ministry of Health initiative under the University of Rwanda. In 2015, a two-year Masters of Science Program was started with eight specialty tracks including Oncology Nursing. The other tracks were Critical Care and Trauma; Nephrology; Pediatrics; Neonatal; Perioperative; Medical-Surgical; and Education, Leadership and Management.

    The Oncology Nursing Stream is a four-semester program and offers education for nurses across cancer screening, diagnosis, treatment and follow-up care of both adults and children. End-of-life care, psychosocial care and cancer rehabilitation topics are incorporated. A thesis is required, and clinical practice components occurs in several hospital, clinic, and home settings.

    To date, three cohorts have graduated, and the 4th and 5th are enrolled. Graduates are assuming clinical and leadership roles in their respective health care facilities as well as faculty positions in Schools of Nursing. Additionally, they are beginning to publish their research and offer presentations at international conferences. The program is building capacity for oncology nursing in the country.

    References

    • Fidler MM, Bray F, Soerjomataram I. The global cancer burden and human development: A review. Scandinavian Journal of Public Health, 2018; 46: 27–36.
    • Uwayezu, M.G., Nizure, B., & Fitch, M.I. (2020). Oncology Nursing Education: Looking Back, Looking Forwards and Rwanda’s Perspective. eCancer Journal, 14,1079.  https://doi.org/10.3332/ecancer.2020.1079
    • Uwayezu, M.G., Nikuze, B., Fitch, M.I (2020). A Focus on Cancer Care and the Nursing Role in Rwanda. Canadian Oncology Nursing Journal, 30(3),  223-226.

    This study was presented at ICCN2022 virtual conference.

    Registration for ICCN2022 virtual library now open. For more information, please access https://www.iccn2022.com/registration/


  • June 16, 2022 3:16 AM | Anonymous

    Reflection
    Author: LING Cheuk Chi Gigi (RN, PhD), The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong

    Throwback to a few years ago, a poll in UK revealed that persons over 50 are more terrified of developing dementia or getting cancer than other chronic illnesses (“Older people are more scared of”, 2014). Meanwhile, living and dying with comorbid cancer and dementia becomes increasingly prominent with the ageing population (McWilliams et al., 2018).

    Family caregivers often devote a considerable time and effort in providing physical and psychosocial care to their loved ones during the end-of-life.  Providing end-of-life care for persons with either dementia or cancer is well-known to be a stressful and burdensome experience (Secinti et al., 2021). The comorbidity of cancer and dementia might further amplify the intricacies of the end-of-life caregiving experience when the person’s physical, cognitive, emotional, and behavioural aspects are affected altogether at the same time by both illnesses. Understanding the unique struggles encountered by this specific group of family caregivers is essential to provide information in the development of nursing interventions to effectively support both the persons with comorbidity and their family caregivers. Nonetheless, limited studies have acknowledged this unique family caregiving experience.

    In view of this, an interpretative phenomenological analysis (IPA) was employed to examine the unique end-of-life caregiving experience among family caregivers of persons with comorbid dementia and cancer (PwDnC). Twenty-one family caregivers of deceased PwDnC with diverse backgrounds and characteristics were recruited purposefully from a palliative care unit in Hong Kong. A total of eighteen semi-structured interviews were done as some caregivers in the same family were interviewed together. The audio recordings were then transcribed and analyzed in accord with the principles of IPA. This study yielded a high volume of information. The findings shared below is only part of the data set that mainly focus on the unique internal struggles that encountered by the family caregivers of PwDnC.

    A main theme of unconfirmable silent suffering is unveiled with two subthemes that capture family caregivers’ internal conflict and perception towards the pain of their loved ones: (1) uncertain silent of dementia and (2) undoubted suffering of cancer. Family caregivers in this study believed cancer was the origin of noxious and yet their loved ones could not express their cancer pain due to the unexpressive nature of dementia. These two fallacious beliefs collided when dementia met cancer and ascribed to a sense of silent suffering and worries in family caregivers of PwDnC. On one hand, family caregivers worried their loved ones were suffering silently. On the other hand, family caregivers were also suffering from their own uncontrollable worries, which resulted in their immobilization and helplessness in providing care and management symptoms.

    These findings give voice to the family caregivers and acknowledge the intricacy of family caregiving in the context of comorbid cancer and dementia. From the findings, we could see that the cancer diagnosis, the grave prognosis, and the possible interactions of all the new and preexisting signs and symptoms might increase family caregivers’ sense of uncertainty and resulting in impertinent worries regarding cancer pain. Taking account of the diversity of family caregivers, careful considerations is needed to develop appropriate assessment and relevant education for this unique group of family caregivers to reduce the ambiguity and uncertainty of caregiving. Further research is suggested to better understand the impact of perceived silent suffering to enable healthcare professionals and family caregivers to provide better care and symptoms management for persons with comorbid cancer and dementia.

    All in all, family caregivers suffered not because of the heavy burden of caregiving, but because they loved and cared about their loved ones.

    Chinese ink on rice paperImage: Captured through my lens: Suffered from your Pain. Chinese ink on rice paper

    Inspired by the data, I created this Chinese Calligraphy during data analysis in 2020. It represents the interpretation and perception of reciprocal suffering through love and caregiving.

    References

    • Older people are more scared of dementia than cancer, poll finds. (2014, August 4). The Telegraph.      https://www.telegraph.co.uk/news/health/elder/11008905/Older-people-are-more-scared-of-dementia-than-cancer-poll-finds.html
    • McWilliams, L., Farrell, C., Grande, G., Keady, J., Swarbrick, C., & Yorke, J. (2018). A systematic           review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care. Aging & Mental Health, 22(10), 1254-1271. https://doi.org/10.1080/13607863.2017.1348476
    • Secinti, E., Lewson, A. B., Wu, W., Kent, E. E., & Mosher, C. E. (2021). Health-Related Quality of Life: A comparative analysis of caregivers of people with Dementia, Cancer, COPD/Emphysema, and Diabetes and Noncaregivers, 2015–2018 BRFSS. Annals of Behavioral Medicine, 55(11), 1130-1143. https://doi.org/10.1093/abm/kaab007

    This study was presented at ICCN2022 virtual conference.

    Registration for ICCN2022 virtual library now open. For more information, please access https://www.iccn2022.com/registration/


  • June 16, 2022 3:09 AM | Anonymous

    Yiyuan Zhao1RNMSNNP, Jingjing WangRNBN, Yanli Wang2RD, Yening Zhang3MD, Ying Zhang1RNBN, Bin Zhang1MDProfessor, Yuhan Lu4RNMSNNP, Professor

    1. The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck, Peking University Cancer Hospital & Institute, Beijing, China

    2. The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Nutrition, Peking University Cancer Hospital & Institute, Beijing, China

    3. The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Psycho-oncology, Peking University Cancer Hospital & Institute, Beijing, China

    4The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Nursing Department, Peking University Cancer Hospital & Institute, Beijing, China

    Rehabilitation management is crucial for postoperative inpatients with head and neck cancer (HNC) to reduce treatment related complications such as excessive salivary flow, anastomotic fistula and poor nutritional status. Recently, we conducted a study that aimed to establish a Nutrition-Rehabilitation Multidisciplinary Team (NRMDT) led by nurses and evaluate the effects of adopting this model in rehabilitation management on improving clinical outcomes among patients with HNC.

    The NRMDT consists of a group of experts--surgeons, oncology nurse specialists, registered nurses, dietitians, palliative care physicians (Figure). The oncology nurse specialist in this department is also a certified Dysphagia Specified Nurse. The NRMDT is led by the oncology nurses who play essential roles in nutritional and symptom assessment, coordination of and monitoring multidisciplinary perioperative care (Table). They also provide a food-intaking-transition training to patients who have postoperative dysphagia (Picture).

    Quasi-experimental design with a sequential sampling method was used in this study. The study was carried out from January 2017 to August 2021. A total of 49 HNC patients recruited were divided into the NRMDT group (n=38) and the control group (n=11). Patients in the control group received usual care from January 2017 to April 2018, whereas those in the NRMDT group were offered nutrition and rehabilitation management during the period of May 2018 to August 2021.Clinical outcomes including rates of weight loss, gastric tube dwelling time, the positive ratio of secretion, the occurrence rates of anatomic fistula, rates of hypoproteinemia, and length of stay were collected. SPSS software V.22.0 was used for data input and statistical analysis. Chi-square and independent-sample t-test were used to evaluate the clinical outcomes between these two groups.  

    The positive ratio of secretion in the NRMDT group was significantly lowerthan that in the control group13.16% versus 45.45%, P=0.02).  Furthermore, 2.63% of patients underwent anastomotic fistula in the NRMDT group, which was significantly lower than that in the control group (36.36%, P=0.01). The participants in the NRMDT group reported the proportion of weight loss and hypoproteinemia was 43.75% and 15.79% respectively, versus 54.54%(p=0.47) and 36.36% (p=0.29) in the control group. The days of gastric dwelling time and hospital length of stay were 16.87±7.91 and 19.89±6.31 in the NRMDT group compared with 21.18±9.87 (p=0.14) and 23.73±10.53 (p=0.27) in the control group.

    This study demonstrated that the model of NRMDT may reduce the positive ratio of secretion and occurrence of anastomotic fistula among patients undergone surgery with HNC. A fullscale study is warranted to examine its effects on improving other clinical outcomes for these patients.

    Appendix

    Figure                  The team members of NRMDT


     


    Picture         Assessment of dysphagia


    Table    Roles of nurses in the NRMDT model

    Oncology nurse specialist

    Registered nurse

    Preoperative stage

    Quality control and management of perioperative and multidisciplinary care

    Assessment of symptoms and food/fluid intake and output, coordination of multidisciplinary care, and timely respond to patients’ needs

    Early stage of postoperative

    Quality control and management of perioperative and multidisciplinary care

    Coordination of multidisciplinary care, provide post-operative care, timely respond to patients’ needs

    Rehabilitation stage

    Assessment of dysphagia, nutritional status, provide food-intaking-transition training to HNC patients

    Implementation of oral intake/ nutrition plan designed by oncology nurse specialist / dietitian

    Stage of discharge and home-nursing

    Follow-up all the discharged cases in the online or face-to-face nursing clinic

    Provision of general health education and evaluation (with other team members if needed)

    This study was presented at ICCN2022 virtual conference.

    Registration for ICCN2022 virtual library now open. For more information, please access https://www.iccn2022.com/registration/


  • June 15, 2022 10:56 PM | Anonymous

    Authors: Yongyi Chen, Yang Liu, Junchen Guo

    Affiliations: the Palliative Care Committee of China Anti Cancer Association (CACA)


    On April 23, Parallel session of Palliative Care for 2021 Chinese Conference on Oncology (CCO) was held online. A total of nearly70,000 experts and representatives have attended this conference.

    Those who share the same aspirations are not far away

    Daiming Fan, the chairman of China Anti Cancer Association (CACA), attended the opening ceremony and delivered a speech. He pointed out that palliative care is at a flourishing stage. As the first palliative care conference for annual CCO, more and more health care workers would benefit from this influential conference. The integrated perspective and multi-dimensional strategies would be applied to improve the whole life cycle health.


    Yazhou Xiao, the Director of the Palliative Care Committee of CACA, extended a welcome speech. He called on palliative care workers to work together for the better palliative care collaboration, the more refined quality improvement, and the higher level of science and technology innovation. The ultimate goal is to achieve the improvement of the quality of life for end-stage patients.

    The video "Journey of Life, Love is always there" filmed by the Association was played at the conference. A book release ceremony for "Love in Peace: narrative stories from the palliative care ward" was held. Prof. Ruixian He, Xiaoxia Xu, Zhangyu Pan, Huiqing Yu, and Yongyi Chen were served as the hosts of the conference.


    Those who are in harmony do not regard the region as the boundary

    The conference comprised of three modules: The development of palliative care, the practice of palliative care, spiritual comfort and quality management of palliative care.

    Concurrent Session 1: The development of palliative care

    The topic of Prof. Yazhou Xiao was"Palliative Care: Protecting the dignity of the last mile of life", shared the review and reflections of understanding the development process of palliative care from various angles, the responsibility of promoting the steady development of palliative care from multiple dimensions, the practice of improving the service capacity of palliative care through multiple channels, and the countermeasures and prospects for the all-round development of palliative care with multilevel assistance. He emphasized that the "last mile" of life is a livelihood project and a system project that requires the joint efforts of all medical staff and even the whole society.



    In "Palliative Care Development in China: Past, Present and Future", Prof. Jin Gu from Peking University Cancer Hospital elaborated on the development and practice of palliative care in four aspects: the unprecedented changes in a century, the changes in doctor-patient relationship, and the construction of palliative care centers, medical humanities and hospital culture. He introduced how to spread the concept of palliative care and led the behavior of medical care, so as to arouse more attention and investment in palliative care from the society.


    Concurrent Session 2: The practice of palliative care

    ProfGuijun Lufrom Tsinghua Changgeng Hospital in Beijing elaborated"Palliative Care Discipline Development and Professional Practice Outlook" in three aspects:re-examination of medical model, palliative care discipline development, and thepractice outlook. He reviewed the demand, current situation, and policy evolution of palliative care in China. He also put forward "four assessments": funeral assessment, burial assessment, grief assessment, and growth assessment, as well as the "five satisfaction": the deceased, bereaved families, teamwork, policy integration, and self-satisfaction.


    Prof. Wenwu Cheng from Fudan University Cancer Hospital shared his in-depth analysis of the difficult issues of palliative care in clinical practice in "Difficult aspects of palliative care in clinical practice". He offered corresponding countermeasures and suggestions on how to promote the concept of palliative care, popularize knowledge and education, formulate corresponding norms to safeguard the rights and interests of all parties, improve the breadth of coverageand perfect the protection system, build a diversified model for quality services.


    Concurrent Session 3:Spiritual comfort and quality management of palliative care

    Prof. Yifang Wang shared his plenary address regarding "Spiritual Comfort at the End of Life in Chinese Cultural Perspective". His speech began with traditional Chinese folklore and expanded to physical, psychological, social, and spiritual palliative care, multiple and multidirectional transmission of holistic concepts, philosophical rhetoric and philosophical categories. He also shared the concept and historical of spirit development, the essence of spirit, and spiritual care from the perspective of care, analyzed the concept of death, near-death experience, and near-death image, and emphasized the importance of spiritual comfort at the end of life.


    Prof. Yongyi Chen of Hunan Cancer Hospital shared the practice of quality management from the perspective of high-quality development of palliative care. She explained in detail the model, assessment tools and management exploration of palliative care quality management around three aspects: opportunity, practice and prospects. She believed that rigorous and scientific quality management will help to realize the systematization of the quality assessment of palliative care and the homogenization and standardization of the quality assessment of palliative care.


    Those who know each other are not thousands of miles away.

    The conference set up an "expert connection" session, three experts discussed online and explored the future development of palliative care.

    Prof. Ping Zhao of the Cancer Foundation of China reviewed the development history of palliative care. He pointed out that although China moved up from the 71st to 53rd in the Death Quality Index released in 2021, there was still significant space for improvement in death quality.


    Prof. Duanqi Liu analyzed the palliative home care model in the context of normalized COVID-19 pandemic. He believes that advanced cancer patients are a rather vulnerable group under the COVID-19. He emphasized it was necessary to realize the integration and coordinated development of needs, resources, and professions from the perspective of integration.


    Prof. ShiyingYu from Tongji Hospital considered that how to transform the realization of palliative care wishes into concrete actions is a question worthy of in-depth consideration. We can refer to the international document, standards, and guidelines on the core elements of palliative care to retain the dignity of terminal patients,

    Prof. Yongyi Chen made a summary of the conference. In the future, the committee will continue to take the responsibility to realize service optimization to get out of the "acceleration" of the high-quality development of palliative care, utilized the ability to press the "fast-forward key" of the high-quality development of palliative care, and carry out popular science education to drive into the "fast lane" of the high-quality development of palliative care.




Blog Submission
Guidelines

Share your expert knowledge with other international oncology nursing professionals in an article or vblog. Open the submission guidelines to learn more.

ISNCC Secretariat
Suite 710 - 1201 West Pender Street, Vancouver, BC V6E 2V2

© 2022 - ISNCC. All rights reserved.
Disclaimer

Powered by Wild Apricot Membership Software